For Healthcare Professionals
Future Events
Past Events
On September 14, 2024, Stanford hosted an outstanding CME ILD conference on "Understanding Genetic Contributors to ILD" at the Li Ka Shing Learning and Knowledge Center. Keynote speaker, Christine Kim Garcia MD, Chief of Pulmonary, Allergy, and Critical Care, Columbia University,Director, Columbia Precision Medicine Initiative, reviewed the current state and future directions of familial Interstitial Lung Disease. Other topics included the radiology findings in patients with familial ILD (fILD), developing drug treatment for genetic telemeropathies, practical considerations for screening and testing for fILD, organ dysfunction in telomerapathy related ILDs, and considerations around lung transplation for fILD. Multidisciplinary case presentations and discussion concluded the day.
2024 Stanford PFF Community Walk raises $8700 for the Pulmonary Fibrosis Foundation!
September 7, 2024
On Saturday, September 7, "Team Stanford" patients, families, friends, and staff gathered in-person at LIttle Marina Green in S.F. to join other Bay Area supporters to celebrate "Pulmonary Fibrosis Awareness Month" sponsored by the Pulmonary Fibrosis Foundation (PFF). Team Stanford placed 3rd out of 23 Bay Area teams and raised nearly $8,700 for the PFF to expedite research, enhance care for individuals affected by the disease, and offer exceptional support and educational resources for patients, caregivers, family members, and healthcare professionals.
Pulmonary fibrosis is a deadly and complex disease that causes progressive scarring in the lungs, and it affects over 200,000 Americans annually with 50,000 people estimated to be diagnosed this year alone. While there is still significant work to be done, progress in the fight against pulmonary fibrosis is being made and your generosity allowed the PFF to expand essential efforts for the PF community. Thank you to all of our supporters!
Pulmonary Fibrosis Foundation Summit 2021 VIRTUAL
November 8-13, 2021
Pulmonary Fibrosis Foundation Summit 2021 VIRTUAL was held virtually this past November. However it is now open for viewing all of the outstanding recorded sessions. Even if you did not previously register, you may now register for $25 to view the sessions until February 20, 2022!
Find out more information and register to not miss the sessions for researchers, clinicians, patients and caregivers!
3rd Annual Stanford Pulmonary Fibrosis Foundation Community Walk raises $2500 for the PFF!
September 19, 2020
Team Stanford" patients, families, friends, and staff gathered virtuallythis year to celebrate "Pulmonary Fibrosis Awareness Month" sponsored by the Pulmonary Fibrosis Foundation (PFF). We raised more than $2,500 for the PFF. Pulmonary fibrosis is a deadly and complex disease that causes progressive scarring in the lungs. PF affects over 200,000 Americans annually and 50,000 people will be diagnosed this year alone. While there is still significant work to be done, progress in the fight against pulmonary fibrosis is being made. Your generosity allowed the PFF to expand essential efforts for the PF community. Thank you!
Diagnosing and Treating Fibrosing Interstitial Lung Diseases
Stanford Interstitial Lung Disease Symposium
February 29, 2020
Stanford University hosted an Interstitial Lung Disease CME conference for MDs, APPs, RNs, and other allied healthcare professionals, entitled: Diagnosing and Treating Fibrosing Interstitial Lung Diseases. The overall goal of this symposium was to provide clinicians an in-depth and interactive seminar on the critical aspects of care for patients with fibrotic interstitial lung diseases (ILDs). Our keynote speaker, Dr. Kevin Brown from National Jewish Health, Denver, CO, addressed the role of anti-fibrotic therapies in non-IPF patients, and whether or not asymptomatic ILD patients should receive treatment. A case-based approach with a focus on radiologic interpretation was used to address management of ILD patients with connective tissue disease, unclassifiable disease, respiratory failure, hypoxemia, and familial lung fibrosis. The symposium attracted 100 attendees and provided a unique opportunity for case-based discussions with leading experts in the field.
The symposium took place at the Stanford University School of Medicine, Li Ka Shing Center for Learning and Knowledge.
2nd Annual Stanford Pulmonary Fibrosis Foundation Community Walk
Interstitial Lung Disease Program
September 14, 2019
"Team Stanford" patients, families, friends, and staff gathered to celebrate "Pulmonary Fibrosis Awareness Day" sponsored by the Pulmonary Fibrosis Foundation (PFF). The Stanford Community Walk on the Stanford Campus started in the medical school courtyard and, led by ILD Program Director Rishi Raj MD, walked to the Cantor Museum where a docent met the group and talked about the significant pieces in the Rodin Sculpture Garden. The event raised more than $3000 for the PFF. Pulmonary fibrosis is a deadly and complex disease that causes progressive scarring in the lungs. PF affects over 200,000 Americans annually and 50,000 people will be diagnosed this year alone. While there is still significant work to be done, progress in the fight against pulmonary fibrosis is being made. Your generosity allows the PFF to expand essential efforts for the PF community. Thank you for your generous support.
Rishi Raj MD, Director, Stanford Interstitial Lung DiseaseProgram, presents School of Medicine Grand Rounds Lecture
Medicine Grand Rounds
December 12, 2018
Dr. Rishi Raj, the Director of Stanford's Interstitial Lung Disease Program, presented "On Diagnosing Interstitial Lung Disease" at the School of Medicine Grand Rounds on Wednesday December 12, 2018 from 8-9am. Dr. Raj presented the rationale for the use of the multidisciplinary team approach used by expert centers, such as Stanford's, to accurately diagnose and treat patients with Interstitial Lung Diseases.
Stanford ILD CME Symposium
February 10, 2018
San Jose Mariott, San Jose